Puerarin alleviates vincristine-induced neuropathic pain and neuroinflammation via inhibition of nuclear factor-κB and activation of the TGF-β/Smad pathway in rats

Hengtao Xie,Yingying Chen,Kairong Du,Wei Wu,Xiaobo Feng
DOI: https://doi.org/10.1016/j.intimp.2020.107060
IF: 5.714
2020-12-01
International Immunopharmacology
Abstract:<p>Chemotherapy-induced neuropathic pain harms the quality of life patients. Vincristine is an often used chemotherapeutic drug that evokes neuralgia via inflammation. Puerarin (Pue) extracted from <em>Puerariae Lobatae Radix</em> has analgesic and anti-inflammatory effects; however, its possible effect and mechanism in vincristine (Vin)-induced neuropathic pain has not been investigated. The present research aimed to explore whether Pue could relieve chemotherapy-evoked neuropathic pain and the underlying mechanism actions. Rat neuropathic pain was established by intraperitoneal injection of vincristine. Pue was orally administered in two dose levels (25 or 50 mg/kg/d) for three weeks. The paw withdrawal latency and paw withdrawal threshold were performed to evaluate the pain behaviors. Inflammatory cytokines in the spinal cord and dorsal root ganglion were measured by ELISA kits. qRT-PCR, western blot, and immunofluorescence staining were employed to measure the level and expression feature of inflammatory cytokines. Our findings showed that Pue improved hyperalgesia and allodynia. Treatment with Pue restored the levels of tumor necrosis factor-α (TNF-α), and IL-1β and increased the levels of transforming growth factor-β (TGF-β), and interleukin-10 (IL-10). On the molecular level, treatment with Pue down-regulated the protein levels of IL-1β, and NF-κBp65 and up-regulated the protein levels of TGF-β, p-Smad2, and p-Smad3 (TGF-β/Smad) in the spinal cord and DRG. Immunofluorescence staining further demonstrated that Pue decreased the NF-κBp65 protein. Our findings imply that Pue relieved chemotherapy-induced neuropathic pain might be attributable to the suppression of inflammation cytokines. The anti-inflammation action of Pue might be associated with the activation of the TGF-β/Smad pathway, a novel mechanism exploring its prophylactic effect in vincristine-induced neuropathic pain.</p>
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is chemotherapy - induced peripheral neuropathy and its associated neuropathic pain. Specifically, the paper studied whether puerarin (Pue) can relieve vincristine (Vin) - induced neuropathic pain in rats and explored its potential mechanism of action. ### Specific problems and background 1. **Neuropathic pain caused by chemotherapy drugs** - Long - term use of chemotherapy drugs such as vincristine can lead to severe peripheral neuropathy, which in turn causes neuropathic pain and seriously affects the quality of life of patients. - Currently, drugs used to treat chemotherapy - induced neuropathic pain (such as opioids, anticonvulsants, and antidepressants) have various side effects, which limit their clinical applications. 2. **The role of inflammatory responses in neuropathic pain** - Inflammatory mediators are closely related to the occurrence and development of peripheral neuropathy. Excessive secretion of pro - inflammatory factors (such as TNF - α, IL - 1β) in the spinal cord, dorsal root ganglia, and nerves may lead to persistent neuropathic pain. - On the other hand, nerve cells can produce anti - inflammatory factors (such as TGF - β, IL - 10), which help to reduce pain and inflammatory responses, and thus may slow down the development of nerve damage and neuropathic pain. 3. **The potential role of puerarin** - Puerarin is the main active ingredient extracted from Pueraria lobata, and has multiple pharmacological effects, including antioxidant, antitumor, and anti - inflammatory effects. - Previous studies have shown that puerarin has potential efficacy in diabetes complications, cancer, Alzheimer's disease, and cerebrovascular diseases. - However, the role of puerarin in vincristine - induced neuropathic pain and its mechanism are not yet clear. ### Research purposes This study aims to explore whether puerarin can relieve vincristine - induced neuropathic pain in rats by activating the TGF - β/Smad signaling pathway and to reveal its potential molecular mechanism. ### Main findings 1. **Behavioral experiments** - Puerarin significantly improved vincristine - induced mechanical allodynia and thermal allodynia. 2. **Changes in the levels of inflammatory factors** - Puerarin decreased the levels of pro - inflammatory factors TNF - α and IL - 1β, while increasing the levels of anti - inflammatory factors TGF - β and IL - 10. 3. **Molecular mechanism** - At the molecular level, puerarin down - regulated the protein expressions of IL - 1β and NF - κB p65, and up - regulated the protein expressions of TGF - β, p - Smad2, and p - Smad3. - Immunofluorescence staining further confirmed that puerarin reduced the expression of NF - κB p65 protein. ### Conclusion Puerarin effectively relieves vincristine - induced neuropathic pain by inhibiting the inflammatory response and activating the TGF - β/Smad signaling pathway. Therefore, puerarin may become a potential adjuvant drug for the treatment of chemotherapy - induced neuropathic pain.